Clinical Trials Logo

Femoral Artery Occlusion clinical trials

View clinical trials related to Femoral Artery Occlusion.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT04343196 Completed - Clinical trials for Peripheral Arterial Disease

Digital Variance Angiography in Diagnostic Angiographies for Effective Radiation Dose Reduction

Start date: April 21, 2020
Phase: N/A
Study type: Interventional

Digital Variance Angiography (DVA) is a new tool in medical imaging with proven image quality reserve. The previously observed quality reserve of Digital Variance Angiography (DVA) in lower extremity angiographies, allowed to lower radiation exposure by 70 % during DSA in lower extremity diagnostic angiographies with non-inferior image quality. The aim of this study is to apply this non-inferior image quality and use it for radiation exposure reduction in diagnostic lower limb angiography. The project would prospectively block-randomise (50:50) patients, who undergo elective diagnostic angiography into two groups: a comparator group examined by means of conventional DSA using a standard care protocol (Siemens Artis Zee, Extremities Care setting, 1.2 µGy/frame) (Group B) and a study group examined by means of DVA using a low-dose protocol (0.36 µGy/frame corresponding to 70% decrease of radiation dose) (Group A). During each procedure the investigators record radiation exposure (cumulative dosage, dose area product) and contrast media usage and procedural time then compare the results of the groups. Qualitative image review is done to compare conventional DSA and reduced radiation exposure DVA images after image acquisition. Our hypothesis is that with the previously proven non-inferior image quality, the investigators will be able to reduce radiation exposure of the participants and also staff members in everyday clinical practice.

NCT ID: NCT03844724 Completed - Clinical trials for Peripheral Arterial Disease

Drug-eluting PTA Balloon Dilatation Catheter in the Treatment of Peripheral Artery Stenosis or Occlusion

Start date: April 10, 2015
Phase: N/A
Study type: Interventional

Clinical study on safety and efficacy of ZENFlow™ drug-eluting PTA balloon dilatation catheter in the treatment of iliac, femoral and popliteal artery stenosis or occlusion

NCT ID: NCT02720003 Completed - Clinical trials for Femoral Artery Occlusion

A Single Arm Trial Evaluating the BARD Lutonix Drug-Coated Balloon (LTX DCB) for Treatment of Femoropopliteal Arteries

Start date: March 2016
Phase: N/A
Study type: Interventional

To assess the safety and efficacy of the BARD LTX DCB for treatment of stenosis or occlusion of the superficial femoral and popliteal arteries.

NCT ID: NCT02063672 Completed - Restenosis Clinical Trials

Lutonix® Drug Coated Balloon vs. Standard Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

SFA ISR
Start date: March 2014
Phase: N/A
Study type: Interventional

To assess the safety and efficacy of the Lutonix Drug Coated Balloon for treatment of femoropopliteal artery (SFA) in-stent restenosis (ISR).

NCT ID: NCT02013271 Completed - Clinical trials for Femoral Artery Occlusion

Lutonix® DCB for Treatment of Long Lesions in Femoropopliteal Arteries

Start date: December 2013
Phase:
Study type: Observational

To demonstrate efficacy and safety of the Lutonix® Drug Coated Balloon for treatment of long TASC II Class C and D lesions (≥ 14 cm) lesions in the SFA

NCT ID: NCT01947478 Completed - Clinical trials for Femoral Artery Occlusion

MDT-2113 Drug-Eluting Balloon vs. Standard PTA for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery

MDT-2113 SFA
Start date: September 2013
Phase: N/A
Study type: Interventional

The purpose of this trial is to assess the safety and efficacy of MDT-2113 for the interventional treatment of de novo and non-stented restenotic lesions in the superficial femoral artery (SFA) and the proximal popliteal artery (PPA) as compared to treatment with standard percutaneous transluminal angioplasty (PTA).

NCT ID: NCT01816412 Completed - Clinical trials for Femoral Artery Occlusion

LEVANT Japan Clinical Trial

Start date: March 2013
Phase: Phase 2
Study type: Interventional

To demonstrate the safety and efficacy of MD02-LDCB for treatment of stenosis or occlusion of the femoral and popliteal arteries in the Japanese population.

NCT ID: NCT01566461 Completed - Clinical trials for Femoral Artery Occlusion

IN.PACT Admiral Drug-Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Superficial Femoral Artery (SFA) and Proximal Popliteal Artery (PPA)

INPACT SFA II
Start date: March 2012
Phase: N/A
Study type: Interventional

The purpose of the study is to demonstrate the safety and efficacy of the IN.PACT Admiral drug-coated balloon (DCB) in comparison to any standard balloon for treatment of peripheral arterial disease (PAD) in the superficial femoral artery and proximal popliteal artery.

NCT ID: NCT01412541 Completed - Clinical trials for Femoral Artery Occlusion

Moxy Drug Coated Balloon vs. Standard Balloon Angioplasty for the Treatment of Femoropopliteal Arteries

LEVANT 2
Start date: July 2011
Phase: N/A
Study type: Interventional

The purpose of the study is to demonstrate the superior efficacy and non-inferior safety of the Moxy Drug Coated Balloon by direct comparison to standard percutaneous transluminal angioplasty (PTA) catheter for treatment of stenosis of the femoropopliteal arteries.